Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun 18;8(3):544-9.
doi: 10.3980/j.issn.2222-3959.2015.03.19. eCollection 2015.

Treatment of ocular rosacea: comparative study of topical cyclosporine and oral doxycycline

Aysegul Arman  1 , Duriye Deniz Demirseren  2 , Tamer Takmaz  1
Affiliations

Treatment of ocular rosacea: comparative study of topical cyclosporine and oral doxycycline

Aysegul Arman et al. Int J Ophthalmol. .

Abstract

Aim: To compare the effectiveness of topical cyclosporine A emulsion with that of oral doxycycline for rosacea associated ocular changes and dry eye complaints.

Methods: One hundred and ten patients with rosacea were screened. Thirty-eight patients having rosacea associated eyelid and ocular surface changes and dry eye complaints were included in the study. Patients were randomly divided into two groups: nineteen patients were given topical cyclosporine twice daily and nineteen patients were given oral doxycycline 100 mg twice daily for the first month and once daily for the following two months. Symptom and sign scores, ocular surface disease index questionnarie and tear function tests were evaluated at baseline and monthly for 3mo. Three months after results were compared with that of baseline.

Results: Mean values of symptom, eyelid sign and corneal/conjunctival sign scores of each treatment group at baseline and 3mo after treatments were compared and both drugs were found to be effective on rosacea associated ocular changes (P<0.001). Cyclosporine was more effective in symptomatic relief and in the treatment of eyelid signs (P=0.01). There was statistically significant increase in the mean Schirmer score with anesthesia and tear break up time scores in the cyclosporine treatment group compared to the doxycycline treatment group (P<0.05).

Conclusion: Cyclosporine as a topical drug can be used in the treatment of rosacea associated ocular complications because it is more effective than doxycycline. In addition ocular rosacea as a chronic disease requires long term treatment and doxycycline has various side effects limiting its long term usage.

Keywords: cyclosporine A; doxycycline; rosacea.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Change in OSDI scores between baseline and 3mo after treatment.
Figure 2
Figure 2. Change in schirmer scores with anesthesia between baseline and 3mo after treatment.
Figure 3
Figure 3. Change in TBUT scores between baseline and 3mo after treatment.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Steinhoff M, Schauber J, Leyden JJ. New insights into rosacea pathophysiology:a review of recent findings. J Am Acad Dermatol. 2013;69:15–26. - PubMed
    1. Vieira AC, Höfling-Lima AL, Mannis MJ. Ocular rosacea-a review. Arq Bras Oftalmol. 2012;75(5):363–369. - PubMed
    1. Michel JL, Cabibel F. Frequency, severity and treatment of ocular rosacea during cutaneous rosacea. Ann Dermatol Venereol. 2003;130(1):20–24. - PubMed
    1. Wilkin J, Dahl M, Detmar M, Drake L, Liang MH, Odom R, Powell F, National Rosacea Society Expert Committee Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2004;50(6):907–912. - PubMed
    1. Eiseman AS. The ocular manifestations of atopic dermatitis and rosacea. Curr Allergy Asthma Rep. 2006;6(4):292–298. - PubMed

LinkOut - more resources